Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02654418 · ClinicalTrials.gov registry record · NA
Safety Study of SIC 8000 in Subjects Undergoing Endoscopic Mucosal Resection (EMR) of Colonic Lesions Equal to or Larger Than 2 cm
A NA study of Adenomas, sponsored by Cosmo Technologies.
- Completed
- Registry status
- NA
- Development phase
- 226
- Enrollment target
- 5
- Study locations
NCT02654418 is a NA study of Adenomas that has completed, run by Cosmo Technologies. The registered enrollment target is 226 participants. The trial reports 5 study locations across 4 states.
The verdict
NCT02654418, a NA study of Adenomas, has completed, sponsored by Cosmo Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 226 participants
- Enrollment target
- 5
- Study locations
Study Summary
SIC 8000 is indicated for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early-stage cancers or other gastrointestinal mucosal lesions, prior to excision with a snare.
Conditions Studied
Interventions
- PROCEDURE Endoscopic Mucosal Resection of large colon polyps (greater than or equal to 20 mm in size)
Study Locations (5)
Other
- Humanitas Research Hospital & Humanitas University - Milan
- Queen Alexandra Hospital - Portsmouth
Florida
- Mayo Clinic - Jacksonville
Indiana
- Indiana University Hospital - Indianapolis
Missouri
- Kansas City VA Hospital - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 226 participants |
| Start Date | 2016-02 |
| Est. Completion | 2017-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02654418
The ClinicalTrials.gov registry entry for NCT02654418 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 226 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cosmo Technologies, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Adenomas appearing as the primary indexed condition, and to 1 intervention - of which Endoscopic Mucosal Resection of large colon polyps (greater than or equal to 20 mm in size) is the first listed.
NCT02654418 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Other, Florida, Indiana.
Frequently Asked Questions
What is clinical trial NCT02654418 about?
NCT02654418 is a clinical study titled "Safety Study of SIC 8000 in Subjects Undergoing Endoscopic Mucosal Resection (EMR) of Colonic Lesions Equal to or Larger Than 2 cm". SIC 8000 is indicated for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early-stage cancers or other gastrointestinal mucosal lesions, prior to excision with a snare.
What is the current status of trial NCT02654418?
This trial is currently completed. It is a NA study. The enrollment target is 226 participants. The study started on 2016-02. Estimated completion is 2017-07.
What conditions does trial NCT02654418 study?
This clinical trial studies the following conditions: Adenomas.
What interventions are being tested in trial NCT02654418?
The interventions under investigation include: Endoscopic Mucosal Resection of large colon polyps (greater than or equal to 20 mm in size) (PROCEDURE).
Who is sponsoring clinical trial NCT02654418?
This trial is sponsored by Cosmo Technologies, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02654418 being conducted?
This trial has 5 study locations across Florida, Indiana, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.